Tyche Wealth Partners LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Tyche Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 5,902 shares of the financial services provider’s stock, valued at approximately $802,000.

A number of other large investors have also recently bought and sold shares of the business. Glass Jacobson Investment Advisors llc grew its position in shares of iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 122 shares during the last quarter. PCA Investment Advisory Services Inc. bought a new position in iShares Biotechnology ETF in the 2nd quarter worth about $28,000. Values First Advisors Inc. acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $43,000. Horizon Bancorp Inc. IN bought a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $44,000. Finally, Tennessee Valley Asset Management Partners acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $44,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.1 %

Shares of NASDAQ:IBB traded up $0.16 during trading on Wednesday, reaching $127.13. The company had a trading volume of 240,175 shares, compared to its average volume of 1,786,673. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The firm’s fifty day moving average is $135.63 and its 200 day moving average is $129.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.